The expanding role of WEE1

被引：20

作者：

Koh, Siang-Boon ^{[1
]}

机构：

[1] Univ Bristol, Sch Cellular & Mol Med, Biomed Sci Bldg,Univ Walk, Bristol BS8 1TD, Avon, England

来源：

CELLULAR SIGNALLING | 2022年 / 94卷

关键词：

WEE1; DNA damage response; cell cycle checkpoint; epigenetics; tumour immunity; molecularly targeted agents; CYCLE CHECKPOINT KINASE; INHIBITOR AZD1775; DNA-REPLICATION; MITOTIC ENTRY; HISTONE H1; S-PHASE; PHOSPHORYLATES CDC2; COMBINATION THERAPY; OVARIAN-CANCER; SOMATIC WEE1;

D O I：

10.1016/j.cellsig.2022.110310

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

Upon DNA damage, complex transduction cascades are unleashed to locate, recognise and repair affected lesions. The process triggers a pause in the cell cycle until the damage is resolved. Even under physiologic conditions, this deliberate interruption of cell division is essential to ensure orderly DNA replication and chromosomal segregation. WEE1 is an established regulatory protein in this vast fidelity-monitoring machinery. Its involvement in the DNA damage response and cell cycle has been a subject of study for decades. Emerging studies have also implicated WEE1 directly and indirectly in other cellular functions, including chromatin remodelling and immune response. The expanding role of WEE1 in pathophysiology is matched by the keen surge of interest in developing WEE1-targeted therapeutic agents. This review summarises WEE1 involvement in the cell cycle checkpoints, epigenetic modification and immune signalling, as well as the current state of WEE1 inhibitors in cancer therapeutics.

引用

收藏

页数：8

相关论文

共 113 条

[1] Forced Mitotic Entry of S-Phase Cells as a Therapeutic Strategy Induced by Inhibition of WEE1 [J].

Aarts, Marieke ;

Sharpe, Rachel ;

Garcia-Murillas, Isaac ;

Gevensleben, Heidrun ;

Hurd, Melissa S. ;

Shumway, Stuart D. ;

Toniatti, Carlo ;

Ashworth, Alan ;

Turner, Nicholas C. .

CANCER DISCOVERY, 2012, 2 (06) :524-539

[2] Chromatin decondensation in S-phase involves recruitment of Cdk2 by Cdc45 and histone H1 phosphorylation [J].

Alexandrow, MG ;

Hamlin, JL .

JOURNAL OF CELL BIOLOGY, 2005, 168 (06) :875-886

[3] Protein Phosphatase 2A (B55α) Prevents Premature Activation of Forkhead Transcription Factor FoxM1 by Antagonizing Cyclin A/Cyclin-dependent Kinase-mediated Phosphorylation [J].

Alvarez-Fernandez, Monica ;

Halim, Vincentius A. ;

Aprelia, Melinda ;

Mohammed, Shabaz ;

Medema, Rene H. .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (38) :33029-33036

[4] Replication-dependent histone biosynthesis is coupled to cell-cycle commitment [J].

Armstrong, Claire ;

Spencer, Sabrina L. .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2021, 118 (31)

[5] Tome-1, a trigger of mitotic entry, is degraded during G1 via the APC [J].

Ayad, NG ;

Rankin, S ;

Murakami, M ;

Jebanathirajah, J ;

Gygi, S ;

Kirschner, MW .

CELL, 2003, 113 (01) :101-113

[6] Dual Phosphorylation of Cdk1 Coordinates Cell Proliferation with Key Developmental Processes in Drosophila [J].

Ayeni, Joseph O. ;

Varadarajan, Ramya ;

Mukherjee, Oindrila ;

Stuart, David T. ;

Sprenger, Frank ;

Srayko, Martin ;

Campbell, Shelagh D. .

GENETICS, 2014, 196 (01) :197-+

[7] Cyclin-Dependent Kinase Suppression by WEE1 Kinase Protects the Genome through Control of Replication Initiation and Nucleotide Consumption [J].

Beck, Halfdan ;

Nahse-Kumpf, Viola ;

Larsen, Marie Sofie Yoo ;

O'Hanlon, Karen A. ;

Patzke, Sebastian ;

Holmberg, Christian ;

Mejlvang, Jakob ;

Groth, Anja ;

Nielsen, Olaf ;

Syljuasen, Randi G. ;

Sorensen, Claus Storgaard .

MOLECULAR AND CELLULAR BIOLOGY, 2012, 32 (20) :4226-4236

[8] Regulation of cell cycle checkpoint kinase WEE1 by miR-195 in malignant melanoma [J].

Bhattacharya, A. ;

Schmitz, U. ;

Wolkenhauer, O. ;

Schoenherr, M. ;

Raatz, Y. ;

Kunz, M. .

ONCOGENE, 2013, 32 (26) :3175-3183

[9] FURTHER EVIDENCE OF TRANSCRIPTIONAL AND TRANSLATIONAL CONTROL OF HISTONE MESSENGER-RNA DURING HELA S3 CYCLE [J].

BORUN, TW ;

GABRIELLI, F ;

AJIRO, K ;

ZWEIDLER, A ;

BAGLIONI, C .

CELL, 1975, 4 (01) :59-67

[10] MK-1775, a Novel Wee1 Kinase Inhibitor, Radiosensitizes p53-Defective Human Tumor Cells [J].

Bridges, Kathleen A. ;

Hirai, Hiroshi ;

Buser, Carolyn A. ;

Brooks, Colin ;

Liu, Huifeng ;

Buchholz, Thomas A. ;

Molkentine, Jessica M. ;

Mason, Kathryn A. ;

Meyn, Raymond E. .

CLINICAL CANCER RESEARCH, 2011, 17 (17) :5638-5648

← 1 2 3 4 5 6 7 8 9 10 →